LAUNCHES, PROMOTIONS, MERCHANDISING, EVENTS AND OTHER THINGS TO KEEP YOU IN THE KNOW.
MATCHING BUYERS AND SELLERS
The Practice Management Center (PMC), Vision One Credit Union and VSP Global are teaming up through OptometryMatch.com to connect doctors looking to buy or sell an optometry practice. After doctors register on the secure website, PMC matches them with a buyer, seller or practice that meets the specified criteria and provides support and consultation throughout the practice transition process. Vision One Credit Union will provide capital and financial expertise for pre-qualified optometrists. To register, go to OptometryMatch.com.
The U.S. District Court for the Eastern District of Texas ruled that four asserted patents covering Allergan’s RESTASIS are invalid, paving the way for generic alternatives. Allergan transferred the patents to the Saint Regis Mohawk Tribe and was then granted exclusive licenses. Critics of the move, including four U.S. Senators, say that Allergan transferred the patents, hoping to use the tribe’s sovereign immunity to circumvent the inter partes review and keep its monopoly on RESTASIS.
Allergan, whose patent protection for RESTASIS ended in 2014, plans to appeal the court’s ruling. “We have strong arguments for an appeal, and we filed a notice of appeal with the court,” says Brent Saunders, chairman and CEO of Allergan. “If a generic product enters the market, Allergan is ready to mitigate that impact by growing our base business, reducing costs and deploying our balance sheet. We will also deliver on our capital commitments, including increasing our dividend and paying down debt.”
Allergan offers an FAQ document about the court decision on its website.
Go to Allergan.com/Investors/Investors-FAQs.
FDA APPLICATIONS FROM B+L
Bausch + Lomb, a subsidiary of Valeant Pharmaceuticals, Inc., filed a premarket approval application with the U.S. Food and Drug Administration to approve Bausch + Lomb ULTRA contact lenses for up to seven days of continuous wear. ULTRA contact lenses are made of samfilcon A, have a Dk/t value of 163 and feature MoistureSeal Technology, which helps to maintain 95% of lens moisture for a full 16 hours. In other news, the FDA approved the new drug application submitted by B+L and Nicox S.A. for VYZULTA (latanoprostene bunod 0.024%), a prostaglandin analog for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Go to Valeant.com, Bausch.com or Nicox.com
AOA’S GUEST SPEAKER
Aron Ralston captured international headlines in 2003 after a canyoneering accident in Utah left him trapped between two boulders in a remote location for more than five days, ultimately forcing him to sever his own arm with a pocketknife to free himself. Ralston will share his story at the American Optometric Association’s 2018 Optometry’s Meeting, June 20-24, in Denver, during the opening general session event sponsored by Johnson & Johnson Vision. Also, Saturday’s Celebration of Optometry, sponsored by Hoya Vision Care, will feature comedian and TV star Howie Mandel.” Registration and housing are now open. Go to OptometrysMeeting.org.
Paragon Vision Sciences has extended its business partnership with Essilor China, the exclusive distributor of Paragon’s CRT contact lenses in China, by another five years.
Kala Pharmaceuticals, Inc. submitted an NDA for INVELTYS (KPI-121 1%), a topical twice-a-day product candidate for the treatment of inflammation and pain in patients who have undergone ocular surgery.
CovalentCareers, Inc., a California-based career development and digital media company, said it will donate 10% of premium eyecare revenue to the Student Optometric Leadership Network, a private-practice optometry club run entirely by optometry students and recent graduates.